Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …
evidence supplemented by expert clinical consensus and formulate recommendations to …
Nutritional psychiatry: the present state of the evidence
Mental illness, including depression, anxiety and bipolar disorder, accounts for a significant
proportion of global disability and poses a substantial social, economic and heath burden …
proportion of global disability and poses a substantial social, economic and heath burden …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry …
Objectives The therapeutic use of nutrient-based 'nutraceuticals' and plant-based
'phytoceuticals' for the treatment of mental disorders is common; however, despite recent …
'phytoceuticals' for the treatment of mental disorders is common; however, despite recent …
Very long-chain n-3 fatty acids and human health: fact, fiction and the future
PC Calder - Proceedings of the Nutrition Society, 2018 - cambridge.org
EPA and DHA appear to be the most important n-3 fatty acids, but roles for n-3
docosapentaenoic acid are now also emerging. Intakes of EPA and DHA are usually low …
docosapentaenoic acid are now also emerging. Intakes of EPA and DHA are usually low …
Nutritional medicine as mainstream in psychiatry
Psychiatry is at an important juncture, with the current pharmacologically focused model
having achieved modest benefits in addressing the burden of poor mental health worldwide …
having achieved modest benefits in addressing the burden of poor mental health worldwide …
[HTML][HTML] Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities
MA Ortega, MA Álvarez-Mon, C García-Montero… - Molecular …, 2023 - nature.com
Bipolar disorders (BD) represent a severe leading disabling mental condition worldwide
characterized by episodic and often progressive mood fluctuations with manic and …
characterized by episodic and often progressive mood fluctuations with manic and …
Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the …
In the 2011 “Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk
Reduction in Children and Adolescents,” several medical conditions among youth were …
Reduction in Children and Adolescents,” several medical conditions among youth were …
Adjunctive nutraceuticals for depression: a systematic review and meta-analyses
Objective: There is burgeoning interest in augmentation strategies for improving inadequate
response to antidepressants. The adjunctive use of standardized pharmaceutical-grade …
response to antidepressants. The adjunctive use of standardized pharmaceutical-grade …
[HTML][HTML] Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials
G Grosso, A Pajak, S Marventano, S Castellano… - PloS one, 2014 - journals.plos.org
Background Despite omega-3 polyunsaturated fatty acids (PUFA) supplementation in
depressed patients have been suggested to improve depressive symptomatology, previous …
depressed patients have been suggested to improve depressive symptomatology, previous …